Navigation Links
Special Section of JCS Addresses Vascular Anomalies

Hemangiomas, vascular tumors, and other vascular (blood vessel-related) anomalies are potentially disfiguring lesions that cause distress // for affected children and their parents and confusion among physicians and surgeons. Although advances have been made in the diagnosis and treatment of these lesions, many myths, misconceptions, and inaccuracies remain.

To address this situation, the editors of The Journal of Craniofacial Surgery, in collaboration with the American Association of Pediatric Plastic Surgeons, have invited leading international experts to share their views on the current concepts and controversies in treating children with vascular anomalies. The results appear in a Special Section of the July/August issue of JCS.

Over the years, physicians and surgeons have held widely divergent, often inaccurate views regarding vascular anomalies, according to an introductory editorial by Dr. Mutaz B. Habal, Editor of JCS. Hemangiomas, the most common vascular anomaly, are vascular "birthmarks" that can enlarge rapidly. Because many hemangiomas are located on the head and neck, they may cause serious cosmetic problems. Depending on location, damage to the eye or other structures can also occur.

A major problem is that many doctors have been taught that all hemangiomas "will disappear within a short time." However, Dr. Habal writes, "This is absolutely not true…These vascular tumors do not disappear like magic." Some hemangiomas do shrink over time, but may leave behind an area of baggy skin. Others grow very large, causing serious disfigurement if untreated. For many patients, this widespread misconception has led to delays in treatment, cosmetic and psychological issues for the child, and problems with scarring when surgery eventually is performed—not to mention a "windfall for litigation," according to Dr. Habal. Confusion over diagnosis leads to inaccurate identification of vascular tumors and further delays in treatment. < br>
Fortunately, recent years have seen progress in the understanding of vascular anomalies and the development of appropriate treatment protocols. The 20 articles in the Special Section offer "a thorough synopsis" of current scientific understanding of vascular anomalies, their clinical appearance and development, the associated problems, and the treatment options, according to Section Editor Dr. Seth Thaller of the University of Miami.

Dr. Thaller stresses the need for multidisciplinary evaluation to ensure precise identification of vascular anomalies. This information is vital for management decisions—whether it is appropriate to monitor the lesion or to recommend one of several treatment options, alone or in combination.

The development of effective laser techniques has been a major advance in the treatment of vascular anomalies. In a new treatment advance, laser treatment may be performed "intralesionally"—from the inside out. When needed for larger, more complex vascular lesions, modern surgical techniques and skin grafts provide good results. If these procedures are done in childhood, any resulting scars are more easily managed by plastic surgery later on. In some situations, certain drug therapies may play a role.

Several articles in the Special Section outline the current treatment strategies and techniques for patients with hemangiomas and other vascular anomalies. Some authors focus on specific approaches for patients with more complex or rare vascular lesions. Others highlight advances in understanding genetic factors contributing to the development of vascular lesions, which may one day lead to new treatment alternatives.

The goal of the Special Section is to draw attention to the need for a rational, scientifically based approach to diagnosis and treatment of vascular anomalies. Dr. Thaller writes, "Successful management of these challenging lesions requires vigilant planning and diagnosis, proper clinical judgment, thorough knowledge of a range of treatment modalities, indications for intervention, and appreciation of procedure associated peril." The Editors hope that continued scientific and clinical research will lead to new therapeutic advances, "providing our patients and families with new hope for superior outcomes."

Source-Newswise
RM
'"/>




Related medicine news :

1. Special proteins to fight TB identified
2. Special proteins to fight TB identified
3. Specialist care convalesces intensive care survival
4. Specialist surgeon not imperative in melanoma
5. Treating Dental Problems Of Abused Children Need Special Care
6. Specialized Clinics For Manipurs AIDS Patients
7. Credentials Of Specialists Need To Be Checked
8. All Specialty Care Treatments Will Be Offered At Belle Vue.
9. Details of Cosmetic Surgery in a Special Website.
10. Omega-3 May Help Special Children
11. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to ... Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final ... and levels of the game, Connor Sports has committed to a significantly increased focus ...
(Date:5/26/2016)... Pompano Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... Green House® Project offering a new model of care for living and ... on three core values: Meaningful Life in a Real Home provided by Empowered Staff. ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 ... 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world ... Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration ...
(Date:5/26/2016)... ... 26, 2016 , ... Catalent Pharma Solutions, the leading global ... and global clinical supply services, today announced two key appointments and the opening ... and strategic growth plans in the Asia Pacific region. , Howard Kim has ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: